Drugs / ATG S Fresenius
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01810926 | Sep 2011 → Aug 2015 | graft versus host disease | Franco Locatelli | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATG S Fresenius | “ATG S Fresenius” NCT01810926 ↗ |
| Modality | Protein / enzyme biologic | “polyclonal antibody” NCT01810926 ↗ |
| Route | Intravenous | “iv at a dose of 5 mg/kg within 8 hours on day -4,-3,-2 (total dose 15 mg/kg)” NCT01810926 ↗ |